Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12411/768
Full metadata record
DC FieldValueLanguage
dc.contributor.authorFernández M., Enrique-
dc.contributor.authorPadilla A., Paula-
dc.contributor.authorReyes, Christopher-
dc.contributor.authorLisboa, David-
dc.date.accessioned2021-11-18T15:48:12Z-
dc.date.available2021-11-18T15:48:12Z-
dc.date.issued2018-07-01-
dc.identifier.citationFernández, E., Padilla, P., Reyes Ch., Lisboa, D. (2018). Osteonecrosis mandibular relacionada con medicamentos: conceptos teóricos y prácticos actuales para el odontólogo general . Odontología Vital, (2)29, 19-32. https://revistas.ulatina.ac.cr/index.php/odontologiavital/article/view/145/144en_US
dc.identifier.urihttps://revistas.ulatina.ac.cr/index.php/odontologiavital/article/view/145/144-
dc.identifier.urihttps://hdl.handle.net/20.500.12411/768-
dc.description.abstractLa osteonecrosis mandibular relacionada con medicamentos (ONMRM), es un síndrome asociado al uso de fármacos antirresortivos (bifosfonatos), inhibidores de ligando RANK-L y de angiogénesis, administrados para el tratamiento de enfermedades como cáncer y osteoporosis. Objetivos: actualizar contenidos respecto a etiopatogenia y tratamientos de ONMRM, enfatizando el rol del factor “infección”, y en la perspectiva de que el tratamiento, pueda ser implementado por el odontólogo general. Materiales y métodos: se realiza un scoping review mediante acceso a las bases de datos MEDLINE (Pubmed) y Cochrane library, de artículos publicados desde el año 2010 en adelante, en inglés y castellano, empleando palabras claves incluidas en los medical subject headings (MeSH). Conclusiones: La evidencia recogida demuestra que, teniendo en cuenta los factores de riesgo individuales, no existen en general contraindicaciones para llevar a cabo exodoncias, bajo específicos protocolos quirúrgicos, en pacientes con terapias antiresortivas o antiangiogénicas, ya que al parecer, el origen de la ONMRM se asocia a contaminación por biofilm, más que al uso o efecto de estos fármacos. En el caso del tratamiento de una ONMRM ya instalada, las terapias quirúrgicas resultan ser más eficaces que las paliativas en la remisión del cuadro.en_US
dc.description.abstractAbstract: Medication-related osteonecrosis of the jaw (MRONJ) is a syndrome associated to the use of antiresorptive therapy (bisphosphonates), RANK-ligand inhibitors and angiogenesis inhibitors drugs, used for the treatment of cancer and osteoporosis among other diseases. Purpose: Update the knowledge on its etiopathogenesis emphasizing the role of infection, and in doing so, look for treatments that can be carried out by general practitioners. Materials and methods: A scoping review is performed through Medline (Pubmed) and Cochrane databases, of articles published from to 2010, in English and Spanish, including MeSH keywords such as “osteonecrosis of the jaw; “antiresorptive drug”; “bisphosphonates”; “Denosumab”; “surgical wound infection”; “dental extraction”. Conclusions: The current evidence demonstrate that, taking into account individual risk factors, teeth extractions can be harmless performed in patients under antiresorptive or antiangiogenic therapies because the origin of MRONJ appears to be more related to biofilm contamination than with the use or effects of any specific drug. Once MRONJ is installed, surgical therapies prove to be more effective in the treatment and remission of these lesions.-
dc.description.abstractDental trauma is a frequent cause of pulp necrosis in anterior teeth, at an early age, which stops root development and complicates case management. Apexification with calcium hydroxide has been the treatment of choice for many years, however, it requires many appointments and it has been reported that its long-term use can weaken the dentinal walls. With the emergence of materials based on bioceramics, it is possible to perform this type of treatment in a single session and with more predictable results. Therefore, the objective of this article is to show the management of the apexification in an appointment by creating an apical plug with MTA and its follow up to 4 years.-
dc.language.isoesen_US
dc.publisherUniversidad Latina de Costa Ricaen_US
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/us/*
dc.subjectosteonecrosis mandibularen_US
dc.subjectmedicamentos antirresortivosen_US
dc.subjectbifosfonatosen_US
dc.subjectdenosumaben_US
dc.subjectinfección herida quirúrgicaen_US
dc.subjectextracción dentalen_US
dc.subjectosteonecrosis of the jawen_US
dc.subjectantiresorptive drugen_US
dc.subjectbisphosphonatesen_US
dc.subjectdenosumaben_US
dc.subjectsurgical wound infectionen_US
dc.subjectdental extractionen_US
dc.titleOsteonecrosis mandibular relacionada con medicamentos: conceptos teóricos y prácticos actuales para el odontólogo generalen_US
dc.title.alternativeMedication-related osteonecrosis of the jaw: current theoretical and usefulconcepts for the general practitioneren_US
dc.typeArtículoen_US
Appears in Collections:Odontología Vital

Files in This Item:
There are no files associated with this item.


This item is licensed under a Creative Commons License Creative Commons